RUNX1T1 and acute promyelocytic leukemia: In APL and AML1-ETO mouse models in vivo and human cell lines in vitro, HDACi valproic acid upregulates TRAIL, DR5, FasL and Fas in leukemic cells but not normal progenitors, thus for the sensitivity of HDACi to leukemia a transformed phenotype is required [42].